Long-Term Efficacy of Fremanezumab in Patients with Chronic Migraine and Comorbid Moderate to Severe Depression

被引：0
|
作者：
Lipton, R. B.
Cohen, J. M.
Yang, R.
Ning, X.
Buse, D. C.
机构：
来源：
HEADACHE | 2019年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P144
引用
收藏
页码：115 / 115
页数：1
相关论文
共 50 条
  • [1] Long-Term Efficacy of Fremanezumab in Patients With Chronic Migraine and Comorbid Moderate to Severe Depression
    Lipton, Richard
    Cohen, Joshua
    Yeung, Paul P.
    Yang, Ronghua
    Ning, Xiaoping
    Buse, Dawn
    NEUROLOGY, 2019, 92 (15)
  • [2] Efficacy of Fremanezumab in Patients With Chronic Migraine and Comorbid Moderate to Moderately Severe Depression
    Cohen, Joshua M.
    Yeung, Paul P.
    Aycardi, Ernesto
    Bigal, Marcelo E.
    Yang, Ronghua
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Lipton, Richard B.
    Buse, Dawn C.
    NEUROLOGY, 2018, 90
  • [3] Efficacy of fremanezumab in patients with chronic migraine and comorbid moderate to moderately severe depression
    Cohen, Joshua M.
    Yeung, Paul P.
    Aycardi, Ernesto
    Bigal, Marcelo E.
    Yang, Ronghua
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Lipton, Richard B.
    Buse, Dawn C.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [4] Efficacy of Fremanezumab on Migraine Frequency and Depression in Patients with Chronic Migraine and Comorbid Moderate to Moderately Severe Depression
    Buse, D. C.
    Cohen, J. M.
    Yeung, P. P.
    Aycardi, E.
    Yang, R.
    Bibeau, K.
    Galic, M.
    Seminerio, M. J.
    Lipton, R. B.
    HEADACHE, 2018, 58 : 92 - 92
  • [5] EFFICACY OF FREMANEZUMAB IN PATIENTS WITH MIGRAINE AND COMORBID DEPRESSION
    Buse, Dawn C.
    Cohen, Joshua M.
    Ning, Xiaoping
    Du, Evelyn
    Campos, Verena Ramirez
    Lipton, Richard B.
    CEPHALALGIA, 2020, 40 : 77 - 78
  • [6] Efficacy of fremanezumab in patients with chronic migraine and comorbid moderate to moderately severe depression (vol 19, pg P10, 2018)
    Cohen, Joshua M.
    Yeung, Paul P.
    Aycardi, Ernesto
    Bigal, Marcelo E.
    Yang, Ronghua
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Lipton, Richard B.
    Buse, Dawn C.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [7] Long-Term Efficacy of Fremanezumab in Patients With Chronic Migraine With Concomitant Preventive Medication Use
    Yeung, Paul
    Goadsby, Peter
    Jann, Adelene
    Cohen, Joshua
    Yang, Ronghua
    Ning, Xiaoping
    NEUROLOGY, 2019, 92 (15)
  • [8] Long-Term Efficacy of Fremanezumab in Patients with Chronic Migraine with Concomitant Preventive Medication Use
    Goadsby, P. J.
    Jann, A. E.
    Cohen, J. M.
    Yang, R.
    Ning, X.
    HEADACHE, 2019, 59 : 117 - 118
  • [9] Long-Term Efficacy of Fremanezumab in Patients Who Reverted From a Chronic to an Episodic Migraine Classification
    Lipton, Richard
    Cohen, Joshua
    Yeung, Paul P.
    Yang, Ronghua
    Seminerio, Michael
    Campos, Verena Ramirez
    Singh, Rashmi Halker
    Ailani, Jessica
    NEUROLOGY, 2019, 92 (15)
  • [10] Long-term Efficacy of Fremanezumab in Patients With Chronic or Episodic Migraine Who Were Inadequate Responders to Initial Fremanezumab Treatment
    Silberstein, Stephen D.
    Ortega, Mario
    Elms, Shawn
    Davis, Matthew
    Cohen, Joshua M.
    Seminerio, Michael
    Gross, Nick
    Blumenfeld, Andrew
    NEUROLOGY, 2021, 96 (15)
12345